rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2011-1-10
|
pubmed:abstractText |
To investigate the effect of peroxisome proliferator-activated receptor (PPAR)? agonist bezafibrate and oxidized low density lipoprotein (ox-LDL) on fibroblast growth factor 21 (FGF21) expression and apoptosis in cardiac endothelial cells.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0253-3758
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1113-7
|
pubmed:dateRevised |
2011-10-17
|
pubmed:meshHeading |
pubmed-meshheading:21215149-Animals,
pubmed-meshheading:21215149-Apoptosis,
pubmed-meshheading:21215149-Atherosclerosis,
pubmed-meshheading:21215149-Bezafibrate,
pubmed-meshheading:21215149-Cells, Cultured,
pubmed-meshheading:21215149-Endothelium, Vascular,
pubmed-meshheading:21215149-Fibroblast Growth Factors,
pubmed-meshheading:21215149-Lipoproteins, LDL,
pubmed-meshheading:21215149-PPAR alpha,
pubmed-meshheading:21215149-Rats,
pubmed-meshheading:21215149-Rats, Wistar
|
pubmed:year |
2010
|
pubmed:articleTitle |
[Oxidized low density lipoprotein and peroxisome proliferator-activated receptor ? induced endogenous fibroblast growth factor 21 upregulation is protective against apoptosis in cardiac endothelial cells].
|
pubmed:affiliation |
Department of Cardiology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing 100029, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|